HUE056881T2 - Antiproliferatív hatású 2-deoxi-monoszaccharid észterek - Google Patents

Antiproliferatív hatású 2-deoxi-monoszaccharid észterek

Info

Publication number
HUE056881T2
HUE056881T2 HUE14780343A HUE14780343A HUE056881T2 HU E056881 T2 HUE056881 T2 HU E056881T2 HU E14780343 A HUE14780343 A HU E14780343A HU E14780343 A HUE14780343 A HU E14780343A HU E056881 T2 HUE056881 T2 HU E056881T2
Authority
HU
Hungary
Prior art keywords
deoxy
monosaccharides
esters
proliferative activity
anti proliferative
Prior art date
Application number
HUE14780343A
Other languages
English (en)
Inventor
Waldemar Priebe
Marcin Cybulski
Izabela Fokt
Stanislaw Skora
Charles Conrad
Tomothy Madden
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of HUE056881T2 publication Critical patent/HUE056881T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE14780343A 2013-04-05 2014-04-04 Antiproliferatív hatású 2-deoxi-monoszaccharid észterek HUE056881T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361809110P 2013-04-05 2013-04-05

Publications (1)

Publication Number Publication Date
HUE056881T2 true HUE056881T2 (hu) 2022-03-28

Family

ID=51659460

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14780343A HUE056881T2 (hu) 2013-04-05 2014-04-04 Antiproliferatív hatású 2-deoxi-monoszaccharid észterek

Country Status (7)

Country Link
US (3) US10201554B2 (hu)
EP (2) EP3939595A1 (hu)
JP (1) JP6545660B2 (hu)
ES (1) ES2897699T3 (hu)
HU (1) HUE056881T2 (hu)
PL (1) PL2981270T3 (hu)
WO (1) WO2014165736A2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056881T2 (hu) 2013-04-05 2022-03-28 Univ Texas Antiproliferatív hatású 2-deoxi-monoszaccharid észterek
JP2022506579A (ja) * 2018-11-09 2022-01-17 アールエムディー サイエンシズ インコーポレイテッド がん及び他の状態の治療用組成物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103197A (en) 1980-01-21 1981-08-18 Wakamoto Pharmaceut Co Ltd Novel d-glucose derivative and antitumor agent containing the same as active constitutent
JPS58167582A (ja) 1982-03-29 1983-10-03 Takeda Chem Ind Ltd 糖ケタ−ルの製造法
US6319695B1 (en) 1991-10-15 2001-11-20 The Scripps Research Insitute Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
CN1196059A (zh) 1995-06-23 1998-10-14 牛津糖科学(英国)有限公司 治疗化合物
DE19631221C2 (de) 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
EE200200565A (et) 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
CA2317305A1 (en) 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
EP1401483A1 (en) 2001-06-11 2004-03-31 Transition Therapeutics Inc. Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
WO2003018598A2 (en) 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
US7001888B2 (en) 2002-03-29 2006-02-21 Threshold Pharmaceuticals, Inc. Compositions and methods for treating cancer
DE10231370B4 (de) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
JP2006515883A (ja) 2003-01-10 2006-06-08 スレッシュオールド ファーマシューティカルズ， インコーポレイテッド ２−デオキシグルコースによる癌の処置
CA2431425A1 (en) 2003-06-05 2004-12-05 Angiogene, Inc. Epas1 gene transfer to improve cell therapy
WO2005065721A2 (en) 2003-12-30 2005-07-21 Board Of Regents, The University Of Texas System Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex
WO2006024491A1 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
JP4203111B2 (ja) 2005-06-28 2008-12-24 パイオニア株式会社 妨害波検出装置および妨害波除去装置
MX2008010833A (es) 2006-02-24 2008-11-12 Univ Texas Compuestos de hexosa para tratar cancer.
WO2007100728A2 (en) 2006-02-24 2007-09-07 University Of Miami Mannose derivatives for killing tumor cells
FR2899588B1 (fr) 2006-04-07 2009-02-27 Oreal Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
WO2009108926A1 (en) 2008-02-29 2009-09-03 Board Of Regents, The University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
EP1881000A1 (en) 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
WO2008131024A1 (en) 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Iodo-hexose compounds useful to treat cancer
WO2010005799A2 (en) * 2008-07-11 2010-01-14 Board Of Regents, The University Of Texas System Novel acetates of 2-deoxy monosaccharides with anticancer activity
EP2663314A2 (en) * 2011-01-11 2013-11-20 The University of Texas M.D. Anderson Cancer Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
WO2012142615A2 (en) 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders
HUE056881T2 (hu) 2013-04-05 2022-03-28 Univ Texas Antiproliferatív hatású 2-deoxi-monoszaccharid észterek

Also Published As

Publication number Publication date
US10201554B2 (en) 2019-02-12
US20190224225A1 (en) 2019-07-25
WO2014165736A3 (en) 2014-11-27
EP3939595A1 (en) 2022-01-19
US11925654B2 (en) 2024-03-12
US20160184336A1 (en) 2016-06-30
ES2897699T3 (es) 2022-03-02
JP2016515627A (ja) 2016-05-30
US11026960B2 (en) 2021-06-08
US20220023326A1 (en) 2022-01-27
EP2981270A4 (en) 2017-01-04
PL2981270T3 (pl) 2022-05-09
EP2981270A2 (en) 2016-02-10
EP2981270B1 (en) 2021-08-25
WO2014165736A2 (en) 2014-10-09
JP6545660B2 (ja) 2019-07-17

Similar Documents

Publication Publication Date Title
HK1220929A1 (zh) 自動注射器
HK1218522A1 (zh) 自動注射器
HK1218521A1 (zh) 自動注射器
IL243360A0 (en) Methods for regulating the activity of cftr
HK1218401A1 (zh) 自動注射器
LT3080100T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
GB201321123D0 (en) Amplification of circular molecules
PL2997117T3 (pl) Zastosowanie estru
HK1218523A1 (zh) 自動注射器
IL279291A (en) Morphic forms of hexadecyloxypropyl-phosphonate esters
HK1224307A1 (zh) 原毒素- 變體及其使用方法
HK1218400A1 (zh) 自動注射器
EP2951761A4 (en) GRAPHICS OF ACTIVITIES
IL244507B (en) A consequence of an insulin analogue
ZA201602831B (en) Use of lactones
HK1218254A1 (zh) 用拉喹莫德治療多發性硬化症
GB201321078D0 (en) Syringe assemblies
IL242491A0 (en) Consequences of glycinamide a-transformed
AP2015008645A0 (en) Methods of handling papaya
PL2981270T3 (pl) Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym
TWM476829U (en) Structure of grille
IL224699A0 (en) Protection of buildings
HK1220133A1 (zh) 改善微血管完整性的方法
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling